EP 3349784 A1 20180725 - GLYCOTARGETING THERAPEUTICS
Title (en)
GLYCOTARGETING THERAPEUTICS
Title (de)
GLYCOTARGETING-THERAPEUTIKA
Title (fr)
AGENTS THÉRAPEUTIQUES DE GLYCOCIBLAGE
Publication
Application
Priority
- US 201514859292 A 20150919
- US 201615185564 A 20160617
- IB 2016001411 W 20160916
Abstract (en)
[origin: WO2017046652A1] Several embodiments of the present disclosure relate to therapeutic compositions configured to target the liver of a subject and that are useful in the treatment or prevention of one or more of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. In several embodiments, the compositions are configured for clearance of a circulating protein or peptide or antibody associated with one or more of the above-mentioned maladies. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.
IPC 8 full level
A61K 39/00 (2006.01); A61K 38/28 (2006.01); A61K 39/35 (2006.01)
CPC (source: EA EP IL KR)
A61K 38/28 (2013.01 - EA); A61K 39/00 (2013.01 - EA); A61K 39/001 (2013.01 - EP IL KR); A61K 39/35 (2013.01 - EA EP IL KR); A61K 47/549 (2017.08 - EP IL KR); A61K 47/58 (2017.08 - EP IL KR); A61P 3/10 (2018.01 - EP KR); A61P 17/00 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 27/02 (2018.01 - EP KR); A61P 29/00 (2018.01 - EP KR); A61P 37/06 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61K 2039/577 (2013.01 - EP IL); C07K 2319/01 (2013.01 - EP IL)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017046652 A1 20170323; AU 2016325073 A1 20180405; AU 2016325073 B2 20230316; AU 2023203475 A1 20230629; BR 112018005409 A2 20181009; CA 2998066 A1 20170323; CN 108430497 A 20180821; CN 108430497 B 20240507; EA 036102 B1 20200929; EA 036102 B9 20201230; EA 201890778 A1 20180831; EP 3349784 A1 20180725; HK 1257845 A1 20191101; IL 257958 A 20180628; IL 257958 B1 20231001; IL 257958 B2 20240201; IL 306015 A 20231101; JP 2018532722 A 20181108; JP 2022028673 A 20220216; JP 2024063005 A 20240510; JP 7082045 B2 20220607; JP 7434248 B2 20240220; KR 20180080195 A 20180711; MX 2018003411 A 20180906
DOCDB simple family (application)
IB 2016001411 W 20160916; AU 2016325073 A 20160916; AU 2023203475 A 20230602; BR 112018005409 A 20160916; CA 2998066 A 20160916; CN 201680064903 A 20160916; EA 201890778 A 20160916; EP 16778870 A 20160916; HK 19100202 A 20190107; IL 25795818 A 20180307; IL 30601523 A 20230918; JP 2018514285 A 20160916; JP 2021173077 A 20211022; JP 2024016855 A 20240207; KR 20187010936 A 20160916; MX 2018003411 A 20160916